A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats - Wikidata - wikimedia - TriplyDB

A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats

A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats

http://www.wikidata.org/entity/Q35136679

about

LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity IL-2/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD.Costimulation Blockade in Kidney Transplantation: An Update CD28-specific immunomodulating antibodies: what can be learned from experimental models?CD4(+)CD25(hi)Foxp3(+) Cells Exacerbate Bleomycin-Induced Pulmonary Fibrosis IL-2/anti-IL-2 complex: a novel strategy of in vivo regulatory T cell expansion in renal injury.Regulatory T cells in Acute and Chronic Kidney Diseases.

P2860

Q28544395-DA055744-6C85-4D4D-B239-D789A376DB43 Q36109177-FAE2A95B-6926-4C3A-9B2B-4DA9B51BC237 Q37375148-BDA037D0-55F2-4851-A88B-3C86638C5286 Q37999397-B77CF459-0D4F-4CFD-B07C-713B414A0792 Q41872888-B2E65D02-262A-4726-9F24-0372079220F5 Q42550720-92E4EE73-C29A-416D-A278-89A14D7E0452 Q45066685-CBC054BB-1419-4256-AB2F-619BF02C5FEA

P2860

A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats

http://www.wikidata.org/entity/Q35136679

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

A superagonistic monoclonal an ...... nephritis in wistar-kyoto rats

@ast

A superagonistic monoclonal an ...... nephritis in wistar-kyoto rats

@en

type

label

A superagonistic monoclonal an ...... nephritis in wistar-kyoto rats

@ast

A superagonistic monoclonal an ...... nephritis in wistar-kyoto rats

@en

prefLabel

A superagonistic monoclonal an ...... nephritis in wistar-kyoto rats

@ast

A superagonistic monoclonal an ...... nephritis in wistar-kyoto rats

@en

P1433

Q35136679-454CDE1C-13A0-4496-959F-86CBA0749EF7

P1476

Q35136679-4979CA22-2398-4E4F-ABA7-BCAC7F929378

P2093

Q35136679-27A13673-5DC6-46CC-A7B9-4222DB0CC738

Q35136679-3E76D40C-95BF-480D-887F-7428EF8C4A45

Q35136679-70D491A3-7D5E-48DD-8472-91BEDEEBFECD

Q35136679-71B63507-6912-40A7-BFF4-CA5879D8E699

Q35136679-86C12CD4-DFB1-429D-AB63-004379816706

Q35136679-9FFD1135-CEBC-4576-BBA7-848ACF5C5964

Q35136679-B49A1F59-2139-436A-9D4A-C13AE207A755

Q35136679-B761ECD4-B514-4BB4-A5C3-86C57F8186FE

Q35136679-C8DC9BE0-E1DA-4DED-BE72-EE24D3C5E9B7

Q35136679-CA9CF8D1-FB91-47D1-A6B9-9161F8FB9933

P2860

Q35136679-013A5017-B0BE-4CD7-80B0-35B33EEF34A8

Q35136679-1A798A9D-48F5-4F7D-ADA5-83E612F6A246

Q35136679-1FFC78FC-5AAC-4D38-A4CD-557ADF400569

Q35136679-23C9A05F-3FAC-4EFB-A439-BB08CDF1902C

Q35136679-2A3D6C71-AB68-47B4-B411-3569F7A6E676

Q35136679-2D2AD723-9544-40D3-8E29-C8F6473509EA

Q35136679-33AEE470-58C6-4494-AA95-FF851BD84C17

Q35136679-3B347607-EF42-449C-BF74-081A1568F9CE

Q35136679-3D432683-03F2-45F6-8A36-3754E086DD9E

Q35136679-3FF5E2D0-87D8-4615-B26A-A7FA0820EDCC

P2888

Q35136679-801A11E1-AC17-40E7-AB20-D28B7FDF0F80

P304

Q35136679-99EDE2D2-2930-4B4C-9834-A29E5A78E167

P31

Q35136679-021F75B9-91BB-407A-BD42-D846FEA23402

P356

Q35136679-EFA4747E-7DD8-4596-BADE-9B4966595E7E

P407

Q35136679-AA0EADFC-0ED6-4774-A3D7-2F6DF480593A

P433

Q35136679-39D81A5F-AC6E-48DD-A6AF-8A8224FD9EBC

P478

Q35136679-C3423397-9ACF-4D2A-97AE-19EBF05308C3

P50

Q35136679-9BC4DDD3-19CE-4EA3-8361-7885FBF617C9

P577

Q35136679-2B8B4BA7-6EF2-4B8C-84A8-839225A649EF

P5875

Q35136679-B5AFBEE7-A976-4F25-914C-889CB393969F

P6179

Q35136679-E5EFB32C-AF29-4922-A13F-0CEA12BB9C5B

P698

Q35136679-5304FE6C-9714-4391-8654-F6E7CC071F46

P921

Q35136679-7A5DF652-6133-4E95-B6A5-43AD37C1B46B

P932

Q35136679-790D5A34-3D41-4924-859E-59051F407388

P356

MOLMED.2010.00229

P1433

Molecular Medicine

P1476

A superagonistic monoclonal an ...... nephritis in wistar-kyoto rats

@en

P2093

Enyu Imai

http://www.w3.org/2001/XMLSchema#string

Isao Matsui

http://www.w3.org/2001/XMLSchema#string

Kengo Furuichi

http://www.w3.org/2001/XMLSchema#string

Kenro Miyasato

http://www.w3.org/2001/XMLSchema#string

Masayuki Mizui

http://www.w3.org/2001/XMLSchema#string

Noritaka Kawada

http://www.w3.org/2001/XMLSchema#string

Shiro Takahara

http://www.w3.org/2001/XMLSchema#string

Takashi Wada

http://www.w3.org/2001/XMLSchema#string

Thomas Hünig

http://www.w3.org/2001/XMLSchema#string

Xiao-Kang Li

http://www.w3.org/2001/XMLSchema#string

P2860

A novel transcription factor, T-bet, directs Th1 lineage commitment

Exploring the full spectrum of macrophage activation

Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists

Control of regulatory T cell development by the transcription factor Foxp3

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells

Crystal structure of a soluble CD28-Fab complex

How regulatory T cells work

Regulatory T cells and immune tolerance

The many faces of macrophage activation

P2888

molmed.2010.00229

P304

686-696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2119/MOLMED.2010.00229

http://www.w3.org/2001/XMLSchema#string

P407

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51046278

http://www.w3.org/2001/XMLSchema#string

P6179

1068965334

http://www.w3.org/2001/XMLSchema#string

P698

21487638

http://www.w3.org/2001/XMLSchema#string

P921

glomerulonephritis

P932

3146602

http://www.w3.org/2001/XMLSchema#string